Non-small Cell Lung Cancer Therapeutics Market – Size and Forecasts up to 2024 – ResearchAndMarkets.com

The “Non-small
Cell Lung Cancer Therapeutics Market: Global Industry Analysis, Trends,
Market Size and Forecasts up to 2024” report has been added to ResearchAndMarkets.com’s
offering.

The report on global non-small cell lung cancer therapeutics market
provides qualitative and quantitative analysis for the period of 2016 to
2024. The report predicts the global non-small cell lung cancer
therapeutics market to grow with a CAGR of 8% over the forecast period
of 2018-2024.

The study on non-small cell lung cancer therapeutics market covers the
analysis of the leading geographies such as North America, Europe,
Asia-Pacific and RoW for the period of 2016 to 2024.

Global Non-small Cell Lung Cancer Therapeutics Market by Drug
Class:

How this report delivers:

1. Comprehensive analysis of global as well as regional markets of
non-small cell lung cancer therapeutics market.

2. Complete coverage of all the segments in non-small cell lung cancer
therapeutics market to analyze the trends, developments in the global
market and forecast of market size up to 2024.

3. Comprehensive analysis of the companies operating in global non-small
cell lung cancer therapeutics market. The company profile includes
analysis of product portfolio, revenue, SWOT analysis and latest
developments of the company.

4. Growth Matrix presents analysis of the product segments and
geographies that market players should focus to invest, consolidate,
expand and/or diversify.

Key Topics Covered:

1. Preface

2. Executive Summary

3. Global Non-small Cell Lung Cancer Therapeutics Market Overview

4. Global Non-small Cell Lung Cancer Therapeutics Market by Drug Class

5. Global Non-small Cell Lung Cancer Therapeutics Market by Region
2018-2024

6. Company Covered

Companies Featured:

For more information about this report visit https://www.researchandmarkets.com/research/wpqx8v/nonsmall_cell?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20180713005185/en/

Leave a Comment